Tolfenamic Acid - Moligand™, 10mM in DMSO , Inhibitor of AKR1C3, CAS No.13710-19-5, Inhibitor of AKR1C3

CAS: 13710-19-5 Cat. No.: T407845 Summenformel: C₁₄H₁₂ClNO₂ Molekulargewicht: 261.7 EG-Nummer: 237-264-3 PubChem CID: 610479

GRADE & PURITY Moligand™, 10mM in DMSO

Synonyms

2-​[(3-​chloro-​2-​methylphenyl)​amino]​-benzoic acid

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Übersicht

Information

Tolfenamic Acid is aCOX-2inhibitor withIC50of 0.2 μM.
In vitro

In vivo

Cell Data

cell lines：RF/MT-2 strains

Concentrations：

Incubation Time：

Powder Purity:≥98%

Specifications

Synonyme

2-​[(3-​chloro-​2-​methylphenyl)​amino]​-benzoic acid

Spezifikationen & Reinheit

Moligand™, 10mM in DMSO

Biochemische und physiologische Mechanismen

Tolfenamic Acid is a COX-2 inhibitor with IC50 of 0.2 μM.

Storage

Store at -80°C

Verschickt in

Dry ice packs + Cold packs

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Aktionsart

INHIBITOR

Mechanismus der Wirkung

Inhibitor of AKR1C3

Namen und Kennungen

• Isomere SMILES: CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O
• WGK Deutschland: 3
• RTECS: CB2687500
• PubChem CID: 610479
• Molekulargewicht: 261.7
• Reaxy-Rn: 657821

Zugehörige Ziele (menschlich)

TTR Tclin Transthyretin (1 Activities)

Discover Target: TTR

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

AKR1C3 Tchem Aldo-keto reductase family 1 member C3 (2 Activities)

Discover Target: AKR1C3

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Chemische und physikalische Eigenschaften

• Löslichkeit: Solubility (25°C) In vitro DMSO: 62 mg/mL (186.25 mM)
• Schmelzpunkt (°C): 209-214°C

Referenzen

1. Guanqiong Na, Xiaofei Hu, Yaning Sun, Guangxu Xing, Yunrui Xing, Gaiping Zhang.  (2020)  A novel gold particle-based paper sensor for sensitively detecting carprofen in bovine muscle.  FOOD AND AGRICULTURAL IMMUNOLOGY,      [PMID:] [10.1080/09540105.2020.1740178]

2. Xinyi Wang, Shijie Xu, Lina Jia, Yujia Yang, Yu Liu, Junbo Gong, Songgu Wu.  (2019)  Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine to improve physicochemical properties for potential veterinary use.  CRYSTENGCOMM,  21  (35): (5284-5291).  [PMID:] [10.1039/C9CE00781D]

3. Xue Shu-Wen, Li Jing, Xu Li.  (2017)  Preparation of magnetic melamine-formaldehyde resin and its application to extract nonsteroidal anti-inflammatory drugs.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  409  (12): (3103-3113).  [PMID:28224244] [10.1007/s00216-017-0251-8]

4. Luo Zhi-yuan, Li Zhi-yong, Liu Hai-yan, Tang Min-qiong, Shi Zhi-guo.  (2015)  Click chemistry-based synthesis of water-dispersible hydrophobic magnetic nanoparticles for use in solid phase extraction of non-steroidal anti-inflammatory drugs.  MICROCHIMICA ACTA,  182  (15): (2585-2591).  [PMID:] [10.1007/s00604-015-1638-x]